摘要
目的探讨MRI多参数联合评价局部进展期乳腺癌新辅助化疗(NAC)疗效的效能。方法回顾性分析127例经术前穿刺、术后病理确诊的局部进展期乳腺癌。分别于NAC前、NAC 2周期后、4周期后行动态MRI增强扫描及DWI成像。按照Miller&Payne改良病理反应性分级,将所有病例分为组织学反应显著(MHR)与组织学非显著反应组(NMHR)。以病理反应性为应变量,分别对NAC 2、4周期后获得的MRI半定量参数进行分析。建立Logistic回归模型并构建新的参数,研究各新构建参数评价乳腺癌NAC反应性的效能。结果 NAC 2周期后新构建参数ROC曲线下面积(Az)为0.80(95%CI:0.72-0.87),大于单独使用癌灶最大径变化率作为评价指标(Az=0.66,95%CI:0.57-0.76)(P〈0.05),最佳截断点1.81,敏感性及特异性分别为76.81%和72.41%;NAC 4周期后,新构建参数ROC曲线下面积(Az)为0.86(95%CI:0.79-0.93),大于单独使用第4周期后癌灶最小ADC(Az=0.75,95%CI:0.67-0.84)及癌灶最大径变化率(Az=0.73,95%CI:0.62-0.80)(P〈0.05)作为评价指标,最佳截断点-1.19,敏感性及特异性分别为84.06%和81.03%。结论 MRI多参数联合评价局部进展期乳腺癌NAC疗效具有较高诊断效能,能充分利用各指标信息。
Objective To discuss the clinical value of MR multi-parameter combination evaluation of the curative effect of neoadjuvant chemotherapy( NAC) for local advanced breast cancer Methods A total of 127 females patients with pathologically-proved local advanced breast cancer were enrolled in this study. Dynamic enhanced MRI and diffusion weighted imaging( DWI) were performed before NAC as well as after 2 and 4 cycles of NAC in all patients. According to Miller Payne modified pathologic reaction grading,the patients were divided into major histological response group( MHR) and non-major histological response group( NMHR). Taking the pathological response as the dependent variable,the semiquantitative MRI parameters obtained after 2 and 4 cycles of NAC were analyzed. The step-wise logistic regression model was established and the new parameters were constructed,and the value of the newly-constructed parameters in assessing the pathologic response to NAC was analyzed. Results After the second cycle of NAC,the area under curve( Az) of the new parameter was 0. 80( 95% CI: 0. 72- 0. 87),which was significantly higher than that obtained by using the variance rate of the maximum diameter alone( Az = 0. 66,95% CI: 0. 57- 0. 76). The optimal diagnostic cut-off point was 1. 81,and the diagnostic sensitivity and specificity were 76. 81% and 72. 41% respectively. After 4 cycle S of NAC,the area under curve( Az) of the new parameter was 0. 86( 95% CI: 0. 79- 0. 93),which was significantly higher than that obtained by using the minimum ADC of tumor( Az = 0. 75,95% CI: 0. 67- 0. 84) or by using the variance rate of the maximum diameter alone( Az = 0. 73,95% CI: 0. 62- 0. 80)( P〈0. 05). The optimal diagnostic cut-off point was- 1. 19,and the diagnostic sensitivity and specificity were 84. 06% and 81. 03% respectively. Conclusion MRI multi-parameter combination evaluation of the curative effect of neoadjuvant chemotherapy for local advanced breast cancer is highly effective,and this method can make full use of MRI information.
出处
《临床放射学杂志》
CSCD
北大核心
2015年第4期539-543,共5页
Journal of Clinical Radiology
基金
医学物理和工程北京市重点实验室开放课题:乳腺MR诊断(编号:2008P03)
关键词
乳腺癌
磁共振成像
新辅助化疗
病理学
联合
Breast cancer Magnetic resonance imaging Neoadjuvant chemotherapy Pathology Combination